July 14, 2022
Via: PharmaphorumIn a statement, the health technology assessment (HTA) organisation said that the two drugs were backed after an agreement with the two developers on pricing that will make them an option for around 3,450 NHS patients. Trodelvy (sacituzumab govitecan) can […]
Manufacturing, Research and Development
April 21, 2022
Via: Biopharma DiveFormerly known as Seattle Genetics, Seagen has grown to become one of the industry’s largest biotechs, with a market value of $26 billion. Seagen’s business is built on antibody drug conjugates, or ADCs, a type of medicine that uses laboratory-engineered […]
March 30, 2023
March 28, 2023
March 23, 2023
March 16, 2023
Copyright © 2023. All rights reserved
